Moreover, there is growing evidence that, apart from its role as a drug carrier, an empty HA-NP with no drug can exert therapeutic effects in T2D and atherosclerosis by suppressing the proinflammatory response in peripheral tissues by blocking CD44 [67,83]. This evidence concerns the gene CD44 and atherosclerosis.